An interventional study of Back2School in School Attendance Problems, sponsored by Norwegian University of Science and Technology. Recruiting at 4 sites in Norway. Open to participants aged 9 Years to 15 Years. Per ClinicalTrials.gov, last updated 2026-10-15.
Sponsored by Norwegian University of Science and Technology · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
In this study we will investigate the effects of an intervention called Back2School, revised and adapted for Norwegian conditions on school attendance. A total of 240 participants will be recruited. All participants who have been enrolled will receive the intervention. Half of the participants will receive the intervention without delay (the experiment group), and the other half will receive it following a 13-week period (the control group). Following consent, screening for eligibility and randomization, the intervention will start with an assessment related to the individual participant and condition at the participants' school. Based on this a shared understanding and an intervention plan is developed. Over a 13-week period the youth, the family and the school, work together guided by the municipal team to increase attendance and solve problems related to this. Assessments will be carried out after the intervention and 6 months later.
Norwegian University of Science and Technology is the lead sponsor of 495 studies on the registry; 47 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
1 The participant has a known diagnosis of autism-spectrum disorder, psychosis, and/or eating disorder.
2. Participant needs acute psychiatric intervention.
Participants randomized to this intervention will receive the 13 week intervention Back2School starting immediately after randomization.
Behavioral: Back2School
Participants randomized to delayed intervention will ha to wait for 13-15 weeks following randomization before the intervention is started. During the waiting phase they can receive treatment as usual
Behavioral: Back2School
The revised Back2S school manual consists of an initial assessment, a case formulation conference, 16 sessions and 3 meetings with different participants (parents, youth, school personnel) over 13 weeks. There is a booster session 12 weeks after the final session and one 24 weeks after the final session.
School attendance
School attendance measured on a daily basis by teacher.
Time frame: Direct: Avg at Baseline, 2 weeks at end (13 weeks from baseline), 2 weeks at 6 months (37 w from baseline) Delayed: Avg at baseline, 2 weeks before start (13 w from baseline) 2 weeks at end (28 w from baseline), 2 weeks at 6 months (54 w from baseline)
General functioning
Impact on daily life as measured by the SDQ impact scale
Time frame: Direct start group: Will be measured at Baseline (T1), Week 15 from baseline (T2), Week 37 from baseline (T3) Delayed access group: Baseline (T1), Week 15 from Baseline (T1a), Week 29 from baseline (T2), Week 54 from baseline (T3)
Change in Quality of life
Measures perceived quality of life as reported by parents and child using Kidscreen 10
Time frame: Direct start group: Will be measured at Baseline (T1), Week 15 from baseline (T2), Week 37 from baseline (T3) Delayed access group: Baseline (T1), Week 15 from Baseline (T1a), Week 29 from baseline (T2), Week 54 from baseline (T3)
Change in symptoms of anxiety
Measures change in symptoms of anxiety as measured by the SCAS reported by parents and child
Time frame: Direct start group: Will be measured at Baseline (T1), Week 15 from baseline (T2), Week 37 from baseline (T3) Delayed access group: Baseline (T1), Week 15 from Baseline (T1a), Week 29 from baseline (T2), Week 54 from baseline (T3)
Change in symptoms of Depression
Change in symptoms of depression reported by child and parents using the SMFQ
Time frame: Direct start group: Will be measured at Baseline (T1), Week 15 from baseline (T2), Week 37 from baseline (T3) Delayed access group: Baseline (T1), Week 15 from Baseline (T1a), Week 29 from baseline (T2), Week 54 from baseline (T3)
Plan to share: No — Not allowed by Norwegian law and therefore not allowed by our ethical board
Started Apr 2026 (actual). Primary completion is estimated for Dec 2028, 32 months after the start.
Start moved once since we started tracking on Sep 25, 2026: Mar 2026 → Apr 2026, on Oct 15, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Norwegian University of Science and Technology →